{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:30:28Z","timestamp":1791549028413,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02900-w","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T06:37:05Z","timestamp":1749796625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MASP1 in stomach adenocarcinoma: linking diagnosis, prognosis, and tumor immunity"],"prefix":"10.1007","volume":"16","author":[{"given":"Chuyu","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanzi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"issue":"7","key":"2900_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41575-022-00591-0","volume":"19","author":"Y Zavros","year":"2022","unstructured":"Zavros Y, Merchant JL. The immune microenvironment in gastric adenocarcinoma. Nat Rev Gastroenterol Hepatol. 2022;19(7):451\u201367. https:\/\/doi.org\/10.1038\/s41575-022-00591-0.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"2900_CR2","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3390\/curroncol29030131","volume":"29","author":"A Hogner","year":"2022","unstructured":"Hogner A, Moehler M. Immunotherapy in gastric Cancer. Curr Oncol. 2022;29(3):1559\u201374. https:\/\/doi.org\/10.3390\/curroncol29030131.","journal-title":"Curr Oncol"},{"issue":"7","key":"2900_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41571-023-00767-w","volume":"20","author":"Y Hirata","year":"2023","unstructured":"Hirata Y, Noorani A, Song S, Wang L, Ajani JA. Early stage gastric adenocarcinoma: clinical and molecular landscapes. Nat Rev Clin Oncol. 2023;20(7):453\u201369. https:\/\/doi.org\/10.1038\/s41571-023-00767-w.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"2900_CR4","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.bbapap.2008.03.020","volume":"1784","author":"A Krarup","year":"2008","unstructured":"Krarup A, Gulla KC, Gal P, Hajela K, Sim RB. The action of MBL-associated Serine protease 1 (MASP1) on factor XIII and fibrinogen. Biochim Biophys Acta. 2008;1784(9):1294\u2013300. https:\/\/doi.org\/10.1016\/j.bbapap.2008.03.020.","journal-title":"Biochim Biophys Acta"},{"issue":"4\u20135","key":"2900_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1078\/0171-2985-00147","volume":"205","author":"K Hajela","year":"2002","unstructured":"Hajela K, Kojima M, Ambrus G, Wong KH, Moffatt BE, Ferluga J, et al. The biological functions of MBL-associated Serine proteases (MASPs). Immunobiology. 2002;205(4\u20135):467\u201375. https:\/\/doi.org\/10.1078\/0171-2985-00147.","journal-title":"Immunobiology"},{"key":"2900_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.molimm.2018.05.018","volume":"102","author":"JY Chen","year":"2018","unstructured":"Chen JY, Cortes C, Ferreira VP, Properdin. A multifaceted molecule involved in inflammation and diseases. Mol Immunol. 2018;102:58\u201372. https:\/\/doi.org\/10.1016\/j.molimm.2018.05.018.","journal-title":"Mol Immunol"},{"key":"2900_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbrc.2021.02.134","volume":"552","author":"K Takahashi","year":"2021","unstructured":"Takahashi K, Banda NK, Holers VM, Van Cott EM. Complement component factor B has thrombin-like activity. Biochem Biophys Res Commun. 2021;552:17\u201322. https:\/\/doi.org\/10.1016\/j.bbrc.2021.02.134.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2900_CR8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/BOR.0000000000000633","volume":"31","author":"P Conigliaro","year":"2019","unstructured":"Conigliaro P, Triggianese P, Ballanti E, Perricone C, Perricone R, Chimenti MS. Complement, infection, and autoimmunity. Curr Opin Rheumatol. 2019;31(5):532\u201341. https:\/\/doi.org\/10.1097\/BOR.0000000000000633.","journal-title":"Curr Opin Rheumatol"},{"key":"2900_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.smim.2018.02.003","volume":"37","author":"M Kolev","year":"2018","unstructured":"Kolev M, Markiewski MM. Targeting complement-mediated immunoregulation for cancer immunotherapy. Semin Immunol. 2018;37:85\u201397. https:\/\/doi.org\/10.1016\/j.smim.2018.02.003.","journal-title":"Semin Immunol"},{"issue":"7","key":"2900_CR10","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1158\/2159-8290.CD-16-1184","volume":"7","author":"D Ajona","year":"2017","unstructured":"Ajona D, Ortiz-Espinosa S, Moreno H, Lozano T, Pajares MJ, Agorreta J, et al. A combined PD-1\/C5a Blockade synergistically protects against lung Cancer growth and metastasis. Cancer Discov. 2017;7(7):694\u2013703. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-1184.","journal-title":"Cancer Discov"},{"key":"2900_CR11","doi-asserted-by":"publisher","first-page":"101642","DOI":"10.1016\/j.smim.2022.101642","volume":"60","author":"E Magrini","year":"2022","unstructured":"Magrini E, Minute L, Dambra M, Garlanda C. Complement activation in cancer: effects on tumor-associated myeloid cells and immunosuppression. Semin Immunol. 2022;60:101642. https:\/\/doi.org\/10.1016\/j.smim.2022.101642.","journal-title":"Semin Immunol"},{"key":"2900_CR12","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.2147\/JIR.S422903","volume":"16","author":"X Gu","year":"2023","unstructured":"Gu X, Shen H, Zhu G, Li X, Zhang Y, Zhang R, et al. Prognostic model and tumor immune microenvironment analysis of Complement-Related genes in gastric Cancer. J Inflamm Res. 2023;16:4697\u2013711. https:\/\/doi.org\/10.2147\/JIR.S422903.","journal-title":"J Inflamm Res"},{"issue":"D1","key":"2900_CR13","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346. https:\/\/doi.org\/10.1093\/nar\/gkac1000.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2900_CR14","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.ccell.2017.05.010","volume":"31","author":"G Abril-Rodriguez","year":"2017","unstructured":"Abril-Rodriguez G, Ribas A, SnapShot. Immune checkpoint inhibitors. Cancer Cell. 2017;31(6):848. https:\/\/doi.org\/10.1016\/j.ccell.2017.05.010.","journal-title":"Cancer Cell"},{"issue":"7","key":"2900_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41573-021-00345-8","volume":"21","author":"AJ Korman","year":"2022","unstructured":"Korman AJ, Garrett-Thomson SC, Lonberg N. The foundations of immune checkpoint Blockade and the ipilimumab approval decennial. Nat Rev Drug Discov. 2022;21(7):509\u201328. https:\/\/doi.org\/10.1038\/s41573-021-00345-8.","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"2900_CR16","doi-asserted-by":"publisher","first-page":"e552","DOI":"10.1016\/S1470-2045(22)00554-X","volume":"23","author":"R Malmberg","year":"2022","unstructured":"Malmberg R, Zietse M, Dumoulin DW, Hendrikx J, Aerts J, van der Veldt AAM, et al. Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab. Lancet Oncol. 2022;23(12):e552\u201361. https:\/\/doi.org\/10.1016\/S1470-2045(22)00554-X.","journal-title":"Lancet Oncol"},{"issue":"21\u201322","key":"2900_CR17","doi-asserted-by":"publisher","first-page":"e1800489","DOI":"10.1002\/pmic.201800489","volume":"19","author":"Y Vandenbrouck","year":"2019","unstructured":"Vandenbrouck Y, Christiany D, Combes F, Loux V, Brun V. Bioinformatics tools and workflow to select blood biomarkers for early Cancer diagnosis: an application to pancreatic Cancer. Proteomics. 2019;19(21\u201322):e1800489. https:\/\/doi.org\/10.1002\/pmic.201800489.","journal-title":"Proteomics"},{"issue":"3","key":"2900_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1158\/0008-5472.CAN-14-1215","volume":"75","author":"J Li","year":"2015","unstructured":"Li J, Jie HB, Lei Y, Gildener-Leapman N, Trivedi S, Green T, et al. PD-1\/SHP-2 inhibits Tc1\/Th1 phenotypic responses and the activation of T cells in the tumor microenvironment. Cancer Res. 2015;75(3):508\u201318. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-1215.","journal-title":"Cancer Res"},{"key":"2900_CR19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3389\/fphar.2019.00624","volume":"10","author":"X Zhao","year":"2019","unstructured":"Zhao X, Liu J, Ge S, Chen C, Li S, Wu X, et al. Saikosaponin A inhibits breast Cancer by regulating Th1\/Th2 balance. Front Pharmacol. 2019;10:624. https:\/\/doi.org\/10.3389\/fphar.2019.00624.","journal-title":"Front Pharmacol"},{"key":"2900_CR20","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3389\/fimmu.2018.01851","volume":"9","author":"J Dobo","year":"2018","unstructured":"Dobo J, Kocsis A, Gal P. Be on target: strategies of targeting alternative and lectin pathway components in Complement-Mediated diseases. Front Immunol. 2018;9:1851. https:\/\/doi.org\/10.3389\/fimmu.2018.01851.","journal-title":"Front Immunol"},{"key":"2900_CR21","doi-asserted-by":"publisher","first-page":"1095313","DOI":"10.3389\/fonc.2023.1095313","volume":"13","author":"S Han","year":"2023","unstructured":"Han S, Jiang D, Zhang F, Li K, Jiao K, Hu J, et al. A new immune signature for survival prediction and immune checkpoint molecules in non-small cell lung cancer. Front Oncol. 2023;13:1095313. https:\/\/doi.org\/10.3389\/fonc.2023.1095313.","journal-title":"Front Oncol"},{"key":"2900_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071792","author":"M Cedzynski","year":"2020","unstructured":"Cedzynski M, Swierzko AS. Components of the lectin pathway of complement in haematologic malignancies. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12071792.","journal-title":"Cancers (Basel)"},{"key":"2900_CR23","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.3389\/fimmu.2018.02742","volume":"9","author":"CA Maestri","year":"2018","unstructured":"Maestri CA, Nisihara R, Mendes HW, Jensenius J, Thiel S, Messias-Reason I, et al. MASP-1 and MASP-2 serum levels are associated with worse prognostic in cervical Cancer progression. Front Immunol. 2018;9:2742. https:\/\/doi.org\/10.3389\/fimmu.2018.02742.","journal-title":"Front Immunol"},{"key":"2900_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119181","author":"Z Nemeth","year":"2023","unstructured":"Nemeth Z, Debreczeni ML, Kajdacsi E, Dobo J, Gal P, Cervenak L. Cooperation of complement MASP-1 with other proinflammatory factors to enhance the activation of endothelial cells. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24119181.","journal-title":"Int J Mol Sci"},{"key":"2900_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biology6010013","author":"H Maiato","year":"2017","unstructured":"Maiato H, Gomes AM, Sousa F, Barisic M. Mechanisms of chromosome congression during mitosis. Biology (Basel). 2017. https:\/\/doi.org\/10.3390\/biology6010013.","journal-title":"Biology (Basel)"},{"key":"2900_CR26","doi-asserted-by":"publisher","first-page":"8816070","DOI":"10.1155\/2020\/8816070","volume":"2020","author":"X Yang","year":"2020","unstructured":"Yang X, Chen L, Mao Y, Hu Z, He M. Progressive and prognostic performance of an extracellular Matrix-Receptor interaction signature in gastric Cancer. Dis Markers. 2020;2020:8816070. https:\/\/doi.org\/10.1155\/2020\/8816070.","journal-title":"Dis Markers"},{"issue":"1","key":"2900_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/imr.12460","volume":"274","author":"J Dobo","year":"2016","unstructured":"Dobo J, Pal G, Cervenak L, Gal P. The emerging roles of mannose-binding lectin-associated Serine proteases (MASPs) in the lectin pathway of complement and beyond. Immunol Rev. 2016;274(1):98\u2013111. https:\/\/doi.org\/10.1111\/imr.12460.","journal-title":"Immunol Rev"},{"issue":"11","key":"2900_CR28","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1242\/dev.087262","volume":"140","author":"JE Prince","year":"2013","unstructured":"Prince JE, Brignall AC, Cutforth T, Shen K, Cloutier JF. Kirrel3 is required for the coalescence of vomeronasal sensory neuron axons into glomeruli and for male-male aggression. Development. 2013;140(11):2398\u2013408. https:\/\/doi.org\/10.1242\/dev.087262.","journal-title":"Development"},{"issue":"5","key":"2900_CR29","doi-asserted-by":"publisher","first-page":"109940","DOI":"10.1016\/j.celrep.2021.109940","volume":"37","author":"J Wang","year":"2021","unstructured":"Wang J, Vaddadi N, Pak JS, Park Y, Quilez S, Roman CA, et al. Molecular and structural basis of olfactory sensory neuron axon coalescence by Kirrel receptors. Cell Rep. 2021;37(5):109940. https:\/\/doi.org\/10.1016\/j.celrep.2021.109940.","journal-title":"Cell Rep"},{"issue":"7","key":"2900_CR30","doi-asserted-by":"publisher","first-page":"153000","DOI":"10.1016\/j.prp.2020.153000","volume":"216","author":"K Chen","year":"2020","unstructured":"Chen K, Zhao R, Yao G, Liu Z, Shi R, Geng J. Overexpression of kin of IRRE-Like protein 1 (KIRREL) as a prognostic biomarker for breast cancer. Pathol Res Pract. 2020;216(7):153000. https:\/\/doi.org\/10.1016\/j.prp.2020.153000.","journal-title":"Pathol Res Pract"},{"key":"2900_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-018-0153-8","volume":"7","author":"S Lundgren","year":"2019","unstructured":"Lundgren S, Fagerstrom-Vahman H, Zhang C, Ben-Dror L, Mardinoglu A, Uhlen M, et al. Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma. Biomark Res. 2019;7:1. https:\/\/doi.org\/10.1186\/s40364-018-0153-8.","journal-title":"Biomark Res"},{"key":"2900_CR32","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.12659\/MSM.910386","volume":"24","author":"MJ Zhang","year":"2018","unstructured":"Zhang MJ, Hong YY, Li N. Overexpression of kin of IRRE-Like protein 1 (KIRREL) in gastric Cancer and its clinical prognostic significance. Med Sci Monit. 2018;24:2711\u20139. https:\/\/doi.org\/10.12659\/MSM.910386.","journal-title":"Med Sci Monit"},{"issue":"1","key":"2900_CR33","doi-asserted-by":"publisher","first-page":"e18020","DOI":"10.1111\/jcmm.18020","volume":"28","author":"T Wang","year":"2024","unstructured":"Wang T, Chen S, Wang Z, Li S, Fei X, Wang T, et al. KIRREL promotes the proliferation of gastric cancer cells and angiogenesis through the PI3K\/AKT\/mTOR pathway. J Cell Mol Med. 2024;28(1):e18020. https:\/\/doi.org\/10.1111\/jcmm.18020.","journal-title":"J Cell Mol Med"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02900-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02900-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02900-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T05:49:15Z","timestamp":1753163355000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02900-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2900"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02900-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"1085"}}